Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 2, 2015, Pages 412-415

  Ahmad, Suhail ^a   Joseph, Leena ^a   Hagen, Ferry ^b   Meis, Jacques F ^b,c   Khan, Ziauddin ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

A. fumigatus; Cyp51A mutations; Invasive aspergillosis; Resistance

Indexed keywords

ITRACONAZOLE; POSACONAZOLE; TRIAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; CYTOCHROME P-450 CYP51A, ASPERGILLUS; CYTOCHROME P450; FUNGAL PROTEIN;

ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; BROTH DILUTION; CONTROLLED STUDY; DILUTION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EPSILOMETER TEST; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS ISOLATION; GENE LOCUS; GENE MUTATION; GENOTYPE; KUWAIT; MIXED CELL CULTURE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; TANDEM REPEAT; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MOLECULAR TYPING; MUTATION;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CLUSTER ANALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GENOTYPE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MUTATION;

EID: 84922471393     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku410     Document Type: Article

References (17)

1. Kontoyiannis DP, Marr KA, Park BJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091-100.
2. Dimopoulos G, Frantzeskaki F, Poulakou G et al. Invasive aspergillosis in the intensive care unit. Ann N Y Acad Sci 2012; 1272: 31-9.
3. Walsh TJ, Anaissie EJ, Denning DWet al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
4. Mikolajewska A, Schwartz S, Ruhnke M. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy. Mycoses 2012; 55: 2-16.
5. Snelders E, MelchersWJ, Verweij PE. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis? Future Microbiol 2011; 6: 335-47.
6. Georgiadou SP, Kontoyiannis DP. The impact of azole resistance on aspergillosis guidelines. Ann N Y Acad Sci 2012; 1272: 15-22.
7. Denning DW, Bowyer P. Voriconazole resistance in Aspergillus fumigatus: should we be concerned? Clin Infect Dis 2013; 57: 521-3.
8. Chowdhary A, Kathuria S, Xu J et al. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 2013; 9: e1003633.
9. Chowdhary A, Sharma C, Hagen F et al. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. Future Microbiol 2014; 9: 697-711.
10. Burgel PR, Baixench MT, Amsellem M et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother 2012; 56: 869-74.
11. Arendrup MC, Jensen RH, Grif K et al. In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration. J Infect Dis 2012; 206: 981-5.
12. Natesan SK, Lamichchane AK, Swaminathan S et al. Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus. Diagn Microbiol Infect Dis 2013; 76: 458-63.
13. Bader O, Weig M, Reichard U et al. cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother 2013; 57: 3513-7.
14. Zhao Y, Stensvold CR, Perlin DS et al. Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases. J Antimicrob Chemother 2013; 68: 1497-504.
15. 34/L98H mutations in outdoor and hospital environment in Kuwait. Environ Res 2014; 133: 20-6.
16. 34/L98H mutations in the cyp51A gene in India. PLoS One 2012; 7: e52871.
17. 34/L98H mutations in the cyp51A gene for rapid detection of triazole-resistant Aspergillus fumigatus isolates. J Clin Microbiol 2014; 52: 2223-7.